CASC3 and tuberculosis: The predicted physicochemical and ADMET properties of the identified BTZ analogs proposed the promising oral bioavailability of PubChem-155-924-621, Pub-Chem-127-032-794, and PubChem-155-923-972 as potential tuberculosis drug candidates.